These data suggest that the improved antitumour immune responses of CD8+NKG2D+ cells are mediated in part by both increased MICA/B in MV-Edm-infected HCCs and increased FasL in CD8+NKG2D+ cells induced by MV-Edm-infected HCC cells. The gene discussed is CD8A; the disease is hepatocellular carcinoma.